Case report: Hashimoto’s thyroiditis after CD19 chimeric antigen receptor T-cell therapy

Chimeric antigen receptor (CAR)-T cell therapy is a novel cell therapeutic approach that is increasingly being used to treat patients with relapsed refractory B-cell lymphoma. Despite the efficacy of CAR T cell therapy, it has various adverse effects that can affect any organ in the body. The applic...

全面介紹

書目詳細資料

Principais autores:	Panpan Chen, Yongming Xia, Wen Lei, Shuhan Zhong, Huawei Jiang, Lingling Ren, Wenbin Qian, Hui Liu
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2022-10-01
叢編:	Frontiers in Immunology
主題:	thyroditis CAR T lyphoma TgAb irAEs
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.995496/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!